The finding that merlin regulates SC NPC growth in a Rac1- and ErbB2-dependent manner firmly establishes a central growth control target for NF2-associated spinal ependymoma, and advocate for further studies addressing the potential use of ErbB2 inhibitors to treat these CNS neoplasms. The gene discussed is NF2; the disease is central nervous system neoplasm.